T1	Disorder 16 40	interstitial pneumonitis
N1 	Reference T1 UMLS:C0206061	interstitial pneumonitis
T2	Pharmacological_substance 57 66	docetaxel
N1000 	Reference T2 MeSH:C067311	docetaxel
T3	Disorder 119 134	prostate cancer
N2 	Reference T3 UMLS:C0376358	prostate cancer
N3 	Reference T3 UMLS:C0600139	prostate cancer
T4	Disorder 214 230	pulmonary injury
N4 	Reference T4 UMLS:C0273115	pulmonary injury
T5	Disorder 414 429	prostate cancer
N5 	Reference T5 UMLS:C0376358	prostate cancer
N6 	Reference T5 UMLS:C0600139	prostate cancer
T7	Disorder 501 525	interstitial pneumonitis
N7 	Reference T7 UMLS:C0206061	interstitial pneumonitis
T8	Disorder 534 552	pulmonary fibrosis
N8 	Reference T8 UMLS:C0034069	pulmonary fibrosis
T9	Pharmacological_substance 747 756	docetaxel
N1001 	Reference T9 MeSH:C067311	docetaxel
T10	Disorder 765 783	pulmonary toxicity
N9 	Reference T10 UMLS:C3714582	pulmonary toxicity
T14	Pharmacological_substance 137 144	Taxanes
N1002 	Reference T14 MeSH:D043823	Taxanes
T16	Speculation_cue 194 203	potential
T6	Subject 374 389	72-year-old man
T18	Pharmacological_substance 468 477	docetaxel
N1003 	Reference T18 MeSH:C067311	docetaxel
T20	Pharmacological_substance 625 639	corticosteroid
N1004 	Reference T20 MeSH:D000305	corticosteroid
T21	Disorder 869 889	respiratory symptoms
N10 	Reference T21 UMLS:C0037090	respiratory symptoms
T22	Coreferring_mention 283 295	these agents
T26	Disorder 329 345	pulmonary damage
T28	Subject 842 855	such patients
T29	Disorder 575 579	died
N11 	Reference T29 UMLS:C1546956	died
N12 	Reference T29 UMLS:C1306577	died
T31	Speculation_cue 303 307	risk
T23	Subject 87 94	patient
